The goal of this project is to define the molecular mechanism by which androgenic steroid withdrawal initiates the onset of a programmed death known as """"""""apoptosis"""""""" in mammalian prostate cells. Currently it is our ability to access this process that provides our main weapon in the fight against prostate cancer. Apoptosis is a genetically-active cell process and requires the prostate cell to synthesize new substances in order to die. Recently, we have obtained evidence that implies that apoptosis occurs when the differentiated prostate cell attempts to proliferate but is unable to complete this process. This hypothesis opens new opportunities for our ability to dissect the molecular mechanism of apoptosis because it implies that some cytokine stimulus must be initiating this process and that the intracellular signaling systems participate in driving the cell to its death. With the intent of better defining the apoptotic stimulus and dissecting the cellular signaling systems involved in apoptosis, the specific aims of the next years of this proposal will be: 1.To characterize the growth factor and cytokine environment of the rat ventral prostate gland during the acute (first 5 days) period following androgen withdrawal. Quantitative RNA-PCR based assays in addition to ribonuclease protection assays and immunochemical procedures will be used to survey the presence of numerous growth factor and cytokine substances during prostatic regression. 2.Involvement of the intracellular second messenger systems in initiating the apoptotic response will be investigated by quantitating changes in the intra-cellular concentrations of cyclic nucleotides during early regression. In addition we will purify and sequence proteins that become tyrosine-phosphorylated rapidly after castration in an attempt to establish whether they are receptors for an apoptotic cytokine substance or whether they mediate the intracellular response for apoptosis by carrying the signal to the nucleus. 3.We will utilize a well-defined prostate explant culture system to identify agents that can modify the ability of rat prostate cells to undergo apoptosis. Ventral prostate cells grown in testosterone-free medium rapidly begin to enter apoptosis. By supplementing back various kinase stimulators/inhibitors and growth factor/cytokines, we can test the role of these factors and cell modifiers.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA047848-06
Application #
2092756
Study Section
Reproductive Endocrinology Study Section (REN)
Project Start
1988-08-01
Project End
1995-03-31
Budget Start
1994-04-01
Budget End
1995-03-31
Support Year
6
Fiscal Year
1994
Total Cost
Indirect Cost
Name
Columbia University (N.Y.)
Department
Urology
Type
Schools of Medicine
DUNS #
064931884
City
New York
State
NY
Country
United States
Zip Code
10027
Raffo, A J; Perlman, H; Chen, M W et al. (1995) Overexpression of bcl-2 protects prostate cancer cells from apoptosis in vitro and confers resistance to androgen depletion in vivo. Cancer Res 55:4438-45
Zhang, X; Colombel, M; Raffo, A et al. (1994) Enhanced expression of p53 mRNA and protein in the regressing rat ventral prostate gland. Biochem Biophys Res Commun 198:1189-94
Colombel, M; Symmans, F; Gil, S et al. (1993) Detection of the apoptosis-suppressing oncoprotein bc1-2 in hormone-refractory human prostate cancers. Am J Pathol 143:390-400
Schumer, M; Colombel, M C; Sawczuk, I S et al. (1992) Morphologic, biochemical, and molecular evidence of apoptosis during the reperfusion phase after brief periods of renal ischemia. Am J Pathol 140:831-8
Walton, G; Buttyan, R; Garcia-Montes, E et al. (1992) Renal growth factor expression during the early phase of experimental hydronephrosis. J Urol 148:510-4
Colombel, M; Olsson, C A; Ng, P Y et al. (1992) Hormone-regulated apoptosis results from reentry of differentiated prostate cells onto a defective cell cycle. Cancer Res 52:4313-9
Connor, J; Buttyan, R; Olsson, C A et al. (1991) SGP-2 expression as a genetic marker of progressive cellular pathology in experimental hydronephrosis. Kidney Int 39:1098-103
Bandyk, M G; Sawczuk, I S; Olsson, C A et al. (1990) Characterization of the products of a gene expressed during androgen-programmed cell death and their potential use as a marker of urogenital injury. J Urol 143:407-13
Slawin, K; Sawczuk, I S; Olsson, C A et al. (1990) Chromosomal assignment of the human homologue encoding SGP-2. Biochem Biophys Res Commun 172:160-4
Katz, A E; Benson, M C; Wise, G J et al. (1989) Gene activity during the early phase of androgen-stimulated rat prostate regrowth. Cancer Res 49:5889-94

Showing the most recent 10 out of 11 publications